Details for: NEXAVAR
Company: BAYER INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02284227 | NEXAVAR | SORAFENIB (SORAFENIB TOSYLATE) | 200 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Summary Safety Review - NEXAVAR (sorafenib) - Thyroid Gland Dysfunction
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy
Summary Safety Review - NEXAVAR (sorafenib) - Thyroid Gland Dysfunction
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.